BCR/ABL1 and BCR are under the transcriptional control of the MYC oncogene

por Sharma, Nitesh, Magistroni, Vera, Piazza, Rocco, Citterio, Stefania, Mezzatesta, Caterina, Khandelwal, Praveen, Pirola, Alessandra, Gambacorti-Passerini, Carlo
Publicado 2015

De novo UBE2A mutations are recurrently acquired during chronic myeloid leukemia progression and interfere with myeloid differentiation pathways

por Magistroni, Vera, Mauri, Mario, D’Aliberti, Deborah, Mezzatesta, Caterina, Crespiatico, Ilaria, Nava, Miriam, Fontana, Diletta, Sharma, Nitesh, Parker, Wendy, Schreiber, Andreas, Yeung, David, Pirola, Alessandra, Readelli, Sara, Massimino, Luca, Wang, Paul, Khandelwal, Praveen, Citterio, Stefania, Viltadi, Michela, Bombelli, Silvia, Rigolio, Roberta, Perego, Roberto, Boultwood, Jacqueline, Morotti, Alessandro, Saglio, Giuseppe, Kim, Dong-Wook, Branford, Susan, Gambacorti-Passerini, Carlo, Piazza, Rocco
Publicado 2019